Diana Alvarado v. HHS - Tdap, Guillain-Barre syndrome (GBS) and/or chronic inflammatory demyelinating polyneuropathy (CIDP) (2026)
Case summary [AI summaries can sometimes make mistakes]
On August 8, 2024, Diana Alvarado filed a petition alleging that influenza and Tdap vaccines administered in her left deltoid on August 22, 2023 caused Guillain-Barre syndrome, or alternatively GBS and/or chronic inflammatory demyelinating polyneuropathy. The stipulation also notes a later October 2, 2023 COVID-19 vaccination with a flu vaccine, and it addresses waiver of any CICP claim as part of the settlement.
Respondent denied that Ms. Alvarado sustained a Table GBS injury, denied that her alleged GBS, CIDP, or residual effects were caused in fact by the flu or Tdap vaccines, and denied that the vaccines caused any other injury.
The public stipulation does not describe the first neurologic symptom, hospitalization, testing, treatment, rehabilitation, or residual limitations. On January 15, 2026, Chief Special Master Brian H.
Corcoran adopted the parties' stipulation and awarded $90,693.72 through counsel's IOLTA account.
Theory of causation
Influenza and Tdap vaccines August 22, 2023 allegedly causing Table GBS or GBS/CIDP; adult, exact age not stated. COMPENSATED by stipulation. Respondent denied Table GBS, causation of GBS/CIDP/residual effects, and other injury. Public text lacks neurologic details; stipulation also references later COVID/flu vaccination and CICP waiver. Award $90,693.72. Chief SM Brian H. Corcoran; petition August 8, 2024; decision January 15, 2026.
Source PDFs
USCOURTS-cofc-1_24-vv-01214